InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-23.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Smither John W, Director. Officer active across 4 companies, notably eFFECTOR Therapeutics, Inc.. Aggregated, 9 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €17k. Activity tracked since 11 September 2023. The latest transaction was filed on 1 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
28,409 sharesCommon StockSEC:0001493152-26-029413:0
6,960 sharesOrdinary SharesSEC:0000950170-25-003570:0
39,541 shares0Common StockSEC:0001415889-24-020778:0
6,250 sharesCommon StockSEC:0001415889-24-016109:0
Ideal exit: 23 Feb 2025 (T+270)
2,793 sharesCommon StockSEC:0001787306-24-000014:0
900 shares@ US$20.78100.0% of flowCommon StockSEC:0001209191-23-049519:0
6,920 shares0Common StockSEC:0001209191-23-049364:0
24,142 sharesCommon StockSEC:0001209191-21-053707:0
24,142 sharesCommon StockSEC:0001209191-21-053707
9 of 9 declarations
About Smither John W
John W. Smither is a Board Member at eFFECTOR Therapeutics, Inc. As a board member, he participates in the governance of the company and provides his expertise to guide strategic decisions. His experience in the biopharmaceutical sector is beneficial for eFFECTOR.
